These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 32710160)

  • 1. Burden of disease associated with X-linked hypophosphataemia in adults: a systematic literature review.
    Seefried L; Smyth M; Keen R; Harvengt P
    Osteoporos Int; 2021 Jan; 32(1):7-22. PubMed ID: 32710160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring the Burden of X-Linked Hypophosphataemia: An Opportunistic Qualitative Study of Patient Statements Generated During a Technology Appraisal.
    Ferizović N; Marshall J; Williams AE; Mughal MZ; Shaw N; Mak C; Gardiner O; Hossain P; Upadhyaya S
    Adv Ther; 2020 Feb; 37(2):770-784. PubMed ID: 31865548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Burden of disease and clinical targets in adult patients with X-linked hypophosphatemia. A comprehensive review.
    Giannini S; Bianchi ML; Rendina D; Massoletti P; Lazzerini D; Brandi ML
    Osteoporos Int; 2021 Oct; 32(10):1937-1949. PubMed ID: 34009447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The international X-linked hypophosphataemia (XLH) registry (NCT03193476): rationale for and description of an international, observational study.
    Padidela R; Nilsson O; Makitie O; Beck-Nielsen S; Ariceta G; Schnabel D; Brandi ML; Boot A; Levtchenko E; Smyth M; Jandhyala R; Mughal Z
    Orphanet J Rare Dis; 2020 Jun; 15(1):172. PubMed ID: 32605590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. X-linked hypophosphatemia: The medical expert's challenges and the patient's concerns on their journey with the disease.
    Hamdy NAT; Harvengt P; Usardi A
    Arch Pediatr; 2021 Oct; 28(7):612-618. PubMed ID: 34593293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring the burden of X-linked hypophosphatemia: a European multi-country qualitative study.
    Lo SH; Lachmann R; Williams A; Piglowska N; Lloyd AJ
    Qual Life Res; 2020 Jul; 29(7):1883-1893. PubMed ID: 32162120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Asia-Pacific Consensus Recommendations on X-Linked Hypophosphatemia: Diagnosis, Multidisciplinary Management, and Transition From Pediatric to Adult Care.
    Munns CF; Yoo HW; Jalaludin MY; Vasanwala R; Chandran M; Rhee Y; But WM; Kong AP; Su PH; Numbenjapon N; Namba N; Imanishi Y; Clifton-Bligh RJ; Luo X; Xia W
    JBMR Plus; 2023 Jun; 7(6):e10744. PubMed ID: 37283655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral health-related quality of life in X-linked hypophosphataemia and osteogenesis imperfecta.
    Gjørup H; Beck-Nielsen SS; Hald JD; Haubek D
    J Oral Rehabil; 2021 Feb; 48(2):160-168. PubMed ID: 33058298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term outcomes for Asian patients with X-linked hypophosphataemia: rationale and design of the SUNFLOWER longitudinal, observational cohort study.
    Kubota T; Fukumoto S; Cheong HI; Michigami T; Namba N; Ito N; Tokunaga S; Gibbs Y; Ozono K
    BMJ Open; 2020 Jun; 10(6):e036367. PubMed ID: 32601114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interdisciplinary management of FGF23-related phosphate wasting syndromes: a Consensus Statement on the evaluation, diagnosis and care of patients with X-linked hypophosphataemia.
    Trombetti A; Al-Daghri N; Brandi ML; Cannata-Andía JB; Cavalier E; Chandran M; Chaussain C; Cipullo L; Cooper C; Haffner D; Harvengt P; Harvey NC; Javaid MK; Jiwa F; Kanis JA; Laslop A; Laurent MR; Linglart A; Marques A; Mindler GT; Minisola S; Yerro MCP; Rosa MM; Seefried L; Vlaskovska M; Zanchetta MB; Rizzoli R
    Nat Rev Endocrinol; 2022 Jun; 18(6):366-384. PubMed ID: 35484227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Higher prevalence of non-skeletal comorbidity related to X-linked hypophosphataemia: a UK parallel cohort study using CPRD.
    Hawley S; Shaw NJ; Delmestri A; Prieto-Alhambra D; Cooper C; Pinedo-Villanueva R; Javaid MK
    Rheumatology (Oxford); 2021 Sep; 60(9):4055-4062. PubMed ID: 33331900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health-related quality of life of X-linked hypophosphatemia in Spain.
    Yanes MIL; Diaz-Curiel M; Peris P; Vicente C; Marin S; Ramon-Krauel M; Hernandez J; Broseta JJ; Espinosa L; Mendizabal S; Perez-Sukia L; Martínez V; Palazón C; Piñero JA; Calleja MA; Espin J; Arborio-Pinel R; Ariceta G
    Orphanet J Rare Dis; 2022 Jul; 17(1):298. PubMed ID: 35906684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Burden of disease of X-linked hypophosphatemia in Japanese and Korean patients: a cross-sectional survey.
    Ito N; Kang HG; Nishida Y; Evins A; Skrinar A; Cheong HI
    Endocr J; 2022 Apr; 69(4):373-383. PubMed ID: 34732603
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential influences on optimizing long-term musculoskeletal health in children and adolescents with X-linked hypophosphatemia (XLH).
    Glorieux FH; Bonewald LF; Harvey NC; van der Meulen MCH
    Orphanet J Rare Dis; 2022 Jan; 17(1):30. PubMed ID: 35101067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient-reported outcomes measures of X-linked hypophosphataemia participants: findings from a prospective cohort study in the UK.
    Cole S; Sanchez-Santos MT; Kolovos S; Javaid MK; Pinedo-Villanueva R
    Orphanet J Rare Dis; 2023 Feb; 18(1):26. PubMed ID: 36755338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. X-linked hypophosphatemic osteomalacia (XLH): Study of 5 adult patients.
    Chacur C; Gonzalez E; Peris P
    Med Clin (Barc); 2023 Mar; 160(5):218-221. PubMed ID: 36517274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical practice guidelines for paediatric X-linked hypophosphataemia in the era of burosumab.
    Sandy JL; Simm PJ; Biggin A; Rodda CP; Wall CL; Siafarikas A; Munns CF
    J Paediatr Child Health; 2022 May; 58(5):762-768. PubMed ID: 35426466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical and molecular characterization of Chilean patients with X-linked hypophosphatemia.
    Jiménez M; Ivanovic-Zuvic D; Loureiro C; Carvajal CA; Cavada G; Schneider P; Gallardo E; García C; Gonzalez G; Contreras O; Collins MT; Florenzano P
    Osteoporos Int; 2021 Sep; 32(9):1825-1836. PubMed ID: 33666701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multidisciplinary patient care in X-linked hypophosphatemic rickets: one challenge, many perspectives.
    Raimann A; Mindler GT; Kocijan R; Bekes K; Zwerina J; Haeusler G; Ganger R
    Wien Med Wochenschr; 2020 Apr; 170(5-6):116-123. PubMed ID: 31993875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Qualitative Research to Explore the Patient Experience of X-Linked Hypophosphatemia and Evaluate the Suitability of the BPI-SF and WOMAC® as Clinical Trial End Points.
    Theodore-Oklota C; Bonner N; Spencer H; Arbuckle R; Chen CY; Skrinar A
    Value Health; 2018 Aug; 21(8):973-983. PubMed ID: 30098676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.